Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal Indomethacin Dose-escalation for PEP Prevention
NCT07247682Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by First Affiliated Hospital of Anhui Medical University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on NCT07247682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247682.